Akagera Medicines

Waltham, MA · Founded 2018 · Privately Held (backing)

Developer of novel liposomal formulations of antibacterial drugs intended to treat tuberculosis. Akagera Medicines is based in Waltham, MA and was founded in 2018. Its last reported valuation was $345 million in Jan 2025. It has raised $62.2 million.

Last reported valuation

$345.0M

Oct 2026

Priced at

—

Total raised

$62.2M

Last round

—

How much has Akagera Medicines raised?

$62.2Macross 0 recorded rounds

Free account

More of Akagera Medicines with a free account

·Watch Akagera Medicines: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Akagera Medicines investors

2 investors are on record for Akagera Medicines, including Coalition for Epidemic Preparedness Innovations and Crocker Ventures.

For fundraisers

Raising for a company like Akagera Medicines?

2 investors have backed Akagera Medicines.

See all 2 investors →

Frequently asked about Akagera Medicines

How much has Akagera Medicines raised?: Akagera Medicines has raised $62.2M in total across 0 recorded funding rounds.